EDGAR Filing Documents for 0001193125-14-351728

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-14-351728

Filing Date

2014-09-24

Accepted

2014-09-24 17:04:11

Documents

Period of Report

2014-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	d786369d20f.htm	20-F	1558523
2	EX-4.13.1	d786369dex4131.htm	EX-4.13.1	53183
3	EX-4.15.1	d786369dex4151.htm	EX-4.15.1	39792
4	EX-4.15.2	d786369dex4152.htm	EX-4.15.2	42024
5	EX-4.16.2	d786369dex4162.htm	EX-4.16.2	6772
6	EX-4.18	d786369dex418.htm	EX-4.18	165844
7	EX-4.19	d786369dex419.htm	EX-4.19	33195
8	EX-4.20	d786369dex420.htm	EX-4.20	162481
9	EX-12.1	d786369dex121.htm	EX-12.1	9143
10	EX-13.1	d786369dex131.htm	EX-13.1	4519
11	GRAPHIC	g786369exa_pg001.jpg	GRAPHIC	9497
	Complete submission text file	0001193125-14-351728.txt		2089677

Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000

Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-35428 | Film No.: 141118866
SIC: 2834 Pharmaceutical Preparations